Non classé
EU HTA Has Begun: What New Joint Clinical Assessments Mean for Access to Digestive Cancer Medicines
From 12 January 2025, new oncology medicines will undergo EU-wide Joint Clinical Assessments (JCAs). This coordinated evaluation aims to accelerate...
Key Takeaways from ESMO GI 2025 on Pancreatic Cancer
Promising new therapies are emerging. Daraxonrasib, a KRAS-targeting pill, is in Phase 3 trials after earlier encouraging results and FDA Breakthro...
DiCE Grants — Autumn 2025
DiCE opens Autumn 2025 grants: unrestricted operational support for Full and Associate Members, plus the €5,000 Wolfram Nolte Memorial Award for ...
VOICE: A Life-Changing Training in Cancer Research
Patient advocates joined VOICE in London for a week of immersive learning at Barts Cancer Institute. Exploring cancer biology, research methods, an...
Promising Advances in Pancreatic Cancer: ASCO 2025 Highlights
Phase III PANOVA-3 trials show that Tumour-Treating Fields Improve Overall Survival Final data from the Phase 3 PANOVA-3 study of tumour treating f...
Amplifying the Patient Voice: Reflections from the WECAN Academy 2025
DiCE Patient Ambassador Mila Ogalla Toledo shares her experience at the WECAN Academy 2025 in Rome—a three-day training for cancer advocates acro...
AIDA Project Uses Artificial Intelligence to Improve Treatment for a Common Cause of Gastric Cancer
The AIDA project has developed an AI system that helps doctors choose more effective treatments for H. pylori, a major cause of gastric cancer. Bas...
A New Chapter for DiCE: Board Chair Shares Vision and Thanks
We welcome our new Board of Directors forming the core leadership of Digestive Cancers Europe. Their leadership will strengthen our mission. We tha...
READI for Inclusion: Making Clinical Trials Fairer for All
The READI Project is paving the way for more inclusive clinical research. Supported by IHI, this 73-partner consortium is tackling exclusion by emp...
Immunotherapy Added to Chemotherapy Shows Breakthrough Results in Early-Stage Gastric Cancer
Global study brings hope to people diagnosed with early-stage gastric cancer, showing that a combination of immunotherapy and chemotherapy may sign...